Medical Psychology

Clinical Medicine Year 2 • Mental Health Care Psychosocial Support Services and Psychotherapy: A Practical Clinical Guide Psychosocial support helps a person remain safe, connected and functional while living with mental illness, trauma, substance use or major life stress. Psychotherapy is a structured, collaborative treatment that uses psychological methods to reduce symptoms, improve coping and support recovery. Neither replaces emergency medical care, medication when indicated, safe housing or protection from violence. The best plan combines clinical treatment with the patient’s own goals, family and community resources. Safety first: A patient with active suicidal intent, violent behaviour, delirium, severe intoxication or withdrawal, psychosis with inability to care for basic needs, catatonia, severe mania or medical instability needs urgent risk management and medical assessment. Supportive conversation or routine therapy must not delay emergency transfer, observation or safeguarding. Learning objectives Explain the difference between psychosocial support, counselling, psychotherapy, psychiatric rehabilitation and social care. Choose an appropriate intervention from the presenting problem, severity, risk, developmental stage, culture, resources and patient preference. Describe the principles and basic structure of supportive therapy, psychoeducation, behavioural activation, CBT, motivational interviewing, interpersonal therapy, family work, group therapy and trauma-informed care. Construct a collaborative safety plan and a practical discharge or referral plan. Recognise when therapy is unsuitable without stabilisation or specialist support and when to escalate. 1. What psychosocial support includes Service or intervention Purpose Examples in practice Psychological first aid Reduce immediate distress and improve safety after crisis or trauma Calm presence, practical help, accurate information, connection with support and protection from further harm Psychoeducation Improve understanding, self-management and early help-seeking Explain diagnosis, medicines, relapse signs, sleep, substances, crisis contacts and follow-up Psychotherapy Change unhelpful thoughts, emotions, behaviours, relationships or trauma responses CBT, behavioural activation, IPT, problem-solving, supportive therapy, family and trauma-focused therapies Social care and protection Reduce environmental drivers of illness and prevent harm Housing, food, income, legal aid, safeguarding, domestic-violence services and child protection Rehabilitation and recovery support Restore roles, function and community participation Occupational therapy, supported education/employment, peer support and social skills Substance-use services Reduce harm, treat dependence and prevent relapse Brief intervention, motivational work, withdrawal care, relapse prevention and referral 2. A stepped, person-centred model Universal support: respectful communication, sleep and activity advice, practical problem-solving, connection and stigma reduction. Focused low-intensity care: psychoeducation, guided self-help, behavioural activation, problem-solving therapy and brief motivational work. Structured therapy: CBT, IPT, family intervention, trauma-focused treatment or substance-use therapy delivered by a trained provider. Specialist and intensive care: multidisciplinary care, crisis response, inpatient treatment, ECT, complex trauma or severe personality and substance-use support. Recovery and maintenance: relapse prevention, peer support, occupational rehabilitation, family work and long-term physical-health care. Stepped care is not a hierarchy of human worth. A person may need a high-intensity intervention immediately, or a low-intensity intervention may be the safest and most acceptable starting point. Review response regularly and step up, step down or change approach with the patient. 3. Preparing for a psychosocial intervention 3.1 Assessment before therapy Presenting problem, goals, onset, maintaining factors and previous treatment response. Suicide, violence, abuse, neglect, exploitation, psychosis, mania, substance use and medical risk. Attention, cognition, hearing, language, literacy and ability to participate. Trauma history and current safety; never require a detailed disclosure before establishing trust. Family, culture, faith, community, gender and social context. Practical barriers: transport, fees, privacy, childcare, work, disability, phone access and treatment availability. 3.2 Consent and therapeutic boundaries Explain the purpose, method, expected duration, alternatives, confidentiality and its limits. Use the patient’s preferred language and a trained interpreter where needed. Agree on appointment length, contact between sessions, missed visits, emergencies and record-keeping. Maintain professional boundaries; avoid dual relationships, financial dependence, gifts that create obligation and unsupervised contact outside the service. Obtain consent before involving family, except where a lawful and necessary disclosure is required to prevent serious harm. 4. Supportive therapy and counselling skills Supportive therapy is often the most useful intervention in emergency and general clinical settings. It does not mean giving vague reassurance. It combines empathy, containment, practical problem-solving, encouragement and realistic hope. Core skills Attend: calm posture, appropriate eye contact, silence, open questions and accurate reflection. Validate: acknowledge that the feeling makes sense without agreeing with an unsafe belief or delusion. Clarify: summarise the problem, priorities, strengths and immediate needs. Normalise carefully: explain that a reaction may be understandable while still requiring treatment. Problem-solve: choose one manageable problem, brainstorm options, select a first step and review the result. Collaborate: ask “What would make this week a little safer or more manageable?” 5. Psychoeducation Psychoeducation is a clinical intervention, not a lecture. Give information in small pieces, check understanding and connect facts to the patient’s life. Explain the working formulation and uncertainty without using stigmatising labels. Describe medicine purpose, onset of benefit, side effects, adherence, interactions, pregnancy considerations and emergency symptoms. Identify relapse signatures: reduced sleep, withdrawal, increased spending, suspiciousness, voices, hopelessness, substance escalation or missed medicine. Teach a written crisis plan with warning signs, coping steps, trusted contacts, emergency numbers and access to urgent care. Include family education with consent: how to communicate, reduce criticism, recognise risk and support appointments. 6. Cognitive behavioural therapy (CBT) CBT links situations, thoughts, emotions, bodily sensations and behaviour. It does not tell a person that symptoms are “all in the mind.” It helps test interpretations, reduce avoidance and build behaviours that improve functioning. 6.1 Basic CBT formulation Element Questions Situation What happened, where, with whom and when? Automatic thought or image What went through your mind? What did you predict? Emotion and body What did you feel emotionally and physically? How intense was it? Behaviour What did you do or avoid? What was the short-term benefit and long-term cost? Alternative response What evidence supports or challenges the thought? What balanced action fits your goal? 6.2 CBT techniques Thought records and evidence review. Behavioural experiments that are safe, ethical and agreed in advance. Graded exposure for anxiety or avoidance, never forced and never used when the person is medically unstable. Behavioural activation: schedule small, meaningful activities

Clinical Medicine Year 2 • Mental Health Care Management of Psychotropic Medicines’ Side Effects: Recognition, Monitoring and Emergency Care Psychotropic medicines can restore sleep, mood, thought and function, but every medicine has a risk–benefit balance. Managing side effects means asking about them proactively, measuring what can be measured, distinguishing a benign effect from a medical emergency, explaining options without blame, and changing treatment safely rather than abandoning an effective medicine unnecessarily. Emergency warning: Fever with rigidity or altered consciousness, severe allergic reaction, seizures, chest pain, syncope, severe rash or mucosal lesions, respiratory depression, serotonin syndrome, neuroleptic malignant syndrome, agranulocytosis, lithium toxicity, severe hypoglycaemia or suspected overdose requires urgent medical assessment. Do not manage a potentially fatal adverse reaction as a routine outpatient complaint. Learning objectives Classify adverse effects by time of onset, mechanism, severity and reversibility. Recognise common and life-threatening reactions to antidepressants, antipsychotics, mood stabilisers, benzodiazepines and ECT. Use baseline and follow-up monitoring to detect metabolic, cardiovascular, neurological, haematological, hepatic, renal and endocrine toxicity. Apply practical first responses to acute dystonia, akathisia, parkinsonism, tardive dyskinesia, serotonin syndrome, neuroleptic malignant syndrome, lithium toxicity and severe drug rashes. Communicate risk, document an adverse drug reaction and report it through local pharmacovigilance systems. 1. A safe response to any suspected side effect Stabilise. Use ABCDE, vital signs, capillary glucose, oxygen saturation and level of consciousness. Call for help early if unstable. Describe the event. Onset, dose and recent changes, timing after each dose, progression, associated symptoms, exposure to other medicines/substances, allergies and previous reactions. Check the medicine list. Include prescriptions, over-the-counter analgesics, antihistamines, herbal products, alcohol, recreational drugs and recently stopped medicines. Decide urgency. Is this expected and tolerable, clinically important but stable, or a life-threatening syndrome? Investigate selectively. ECG, glucose, electrolytes, renal/liver function, full blood count, CK, drug levels, pregnancy test, toxicology or imaging according to the suspected reaction. Modify safely. Reduce, withhold, switch or continue only after considering withdrawal, relapse and the severity of the reaction. Abruptly stopping some medicines creates its own emergency. Explain and record. Tell the patient what happened, what to avoid, the warning symptoms, the follow-up date and who is responsible. Add a clear adverse-reaction entry to the record. 2. Classifying adverse effects Pattern Examples Clinical response Predictable, dose-related Sedation, postural hypotension, tremor, dry mouth, nausea Review dose and timing; reduce burden; treat symptoms; reassess benefit. Time-dependent or cumulative Weight gain, diabetes, tardive dyskinesia, thyroid or renal effects Baseline and scheduled monitoring; early prevention; specialist review. Idiosyncratic Agranulocytosis, myocarditis, severe hepatitis, Stevens–Johnson syndrome Stop or withhold the culprit and arrange urgent medical assessment. Withdrawal or discontinuation SSRI dizziness, benzodiazepine seizures, rebound anxiety, antipsychotic rebound Plan a gradual taper or medically supervised withdrawal. Interaction-related Lithium toxicity with NSAIDs, serotonin syndrome, QT prolongation, respiratory depression Medication reconciliation, targeted tests and urgent interaction management. 3. Antidepressant adverse effects 3.1 Common SSRI and SNRI effects Gastrointestinal: nausea, loose stool and appetite change often improve during the first weeks. Take with food if appropriate and reassess persistent weight loss or dehydration. Sleep and activation: morning dosing may reduce insomnia; night dosing may suit sedation. New agitation, impulsivity, reduced need for sleep or suicidal thinking needs urgent review for activation, bipolarity or akathisia. Sexual dysfunction: reduced libido, delayed orgasm or erectile difficulty can persist. Ask routinely, consider dose/timing changes or a carefully chosen alternative rather than leaving the patient to stop suddenly. Hyponatraemia: suspect new confusion, headache, nausea, seizures or falls, especially in older adults, low body weight or those taking diuretics. Check sodium urgently. Bleeding: serotonin reuptake inhibition can increase gastrointestinal or bruising risk, especially with NSAIDs, aspirin, anticoagulants or antiplatelets. Blood pressure: monitor with SNRIs, particularly venlafaxine and duloxetine. Severe headache, chest pain or marked hypertension needs urgent assessment. 3.2 Serotonin syndrome Serotonin syndrome usually follows a serotonergic combination, overdose or rapid dose escalation. Features include agitation, anxiety, diaphoresis, diarrhoea, tremor, hyperreflexia, inducible or spontaneous clonus, myoclonus, hyperthermia and rapidly changing mental state. Severe cases develop rigidity, seizures, rhabdomyolysis, renal failure and shock. Stop serotonergic agents and seek urgent medical/toxicology advice. Assess airway, breathing, circulation, temperature, glucose, renal function, electrolytes and CK; treat hyperthermia and complications. Use a quiet environment and supervised benzodiazepine treatment according to local emergency protocol; avoid physical struggling and unnecessary stimulation. Do not confuse serotonin syndrome with NMS, anticholinergic toxicity, severe withdrawal, sepsis or stimulant toxicity. Clonus and hyperreflexia favour serotonin excess; lead-pipe rigidity and slower onset favour NMS. 3.3 Antidepressant withdrawal Discontinuation symptoms may include dizziness, “electric shock” sensations, nausea, vivid dreams, irritability, anxiety, sweating, insomnia and flu-like feelings. They are more likely after abrupt cessation, short half-life medicines and long treatment. Distinguish withdrawal from relapse. Explain the plan before changing treatment and taper gradually, often over weeks or longer depending on medicine and patient response. 4. Antipsychotic adverse effects 4.1 Extrapyramidal symptoms (EPS) Reaction Typical onset and features Management principles Acute dystonia Hours to days: painful neck or jaw spasm, oculogyric crisis, tongue protrusion or laryngeal spasm Urgent anticholinergic treatment such as procyclidine or benztropine according to local protocol; protect airway. Continue short oral cover only when clinically indicated. Akathisia Days to weeks: inner restlessness, pacing, inability to sit still, distress and possible suicidality Do not simply increase the antipsychotic. Review dose, switch if appropriate, assess risk; consider propranolol when safe and specialist advice. Drug-induced parkinsonism Weeks: bradykinesia, rigidity, tremor, masked face and gait change Reduce dose or switch; review anticholinergic burden. Avoid routine anticholinergics in older people where cognition is at risk. Tardive dyskinesia Months or years: repetitive lip smacking, tongue movements, chewing, grimacing or choreiform limb movements Document structured movement examination; specialist review, dose/switch strategy and evidence-based treatment where available. Example emergency dosing: local protocols may use procyclidine 5–10 mg IM/IV or benztropine 1–2 mg IM/IV for acute dystonia, with observation and repeat dosing only under trained clinical supervision. Check anticholinergic contraindications and local formulary; a laryngeal dystonia is an airway emergency. 4.2 Neuroleptic malignant syndrome (NMS) Suspect NMS in a patient exposed to dopamine blockade or rapid dose change who

Clinical Medicine Year 2 • Mental Health Care Psychopharmacology and Biological Therapies: Medicines, Monitoring and ECT Psychopharmacology is the rational use of medicines to reduce distress, restore function, prevent relapse and treat dangerous psychiatric syndromes. Biological therapies include medication, electroconvulsive therapy (ECT) and, in specialist services, other neuromodulation treatments. Safe prescribing begins with a formulation and shared decision; it does not begin with a drug name. Educational safety notice: Dose ranges in this guide are common adult educational ranges, not a prescription. Use the current Uganda Clinical Guidelines, National Drug Authority information, hospital formulary, product information, interaction checker and senior supervision. Adjust for age, pregnancy, renal/hepatic function, frailty, comorbidity, indication and previous response. Never stop an anticonvulsant, benzodiazepine, lithium or antipsychotic abruptly without a clinical plan. Learning objectives Explain how to choose a psychotropic medicine from the target syndrome, diagnosis, urgency, comorbidity, patient preference and monitoring capacity. Compare antidepressants, antipsychotics, mood stabilisers, anxiolytics, hypnotics, stimulants and medicines used for substance-related disorders. State important mechanisms, indications, contraindications, interactions, common adverse effects, serious toxicity and monitoring requirements. Recognise serotonin syndrome, neuroleptic malignant syndrome, acute dystonia, akathisia, tardive dyskinesia, lithium toxicity, valproate toxicity and benzodiazepine withdrawal. Explain the preparation, consent, indications, contraindications, adverse effects and aftercare of ECT. Construct a monitoring and patient-education plan that continues after the prescription is written. 1. Before prescribing: a safe clinical framework Define the target. Name the syndrome or symptom to treat: psychosis, mania, depression, anxiety, insomnia, agitation, catatonia, withdrawal or relapse prevention. Exclude urgent mimics. Check delirium, intoxication/withdrawal, hypoglycaemia, infection, epilepsy, endocrine disease, head injury and medication toxicity. Assess risk. Suicide, violence, vulnerability, self-neglect, pregnancy, overdose access, QT risk and ability to follow monitoring all influence the plan. Choose the least burdensome effective option. Consider previous response, adverse effects, comorbidity, interactions, cost, availability, route and the patient’s preference. Obtain baseline information. Weight/BMI, pulse, blood pressure, glucose/HbA1c, lipids, renal/liver function, thyroid function, pregnancy status, ECG and movement examination when indicated. Start low and review deliberately. Titrate according to response and tolerability; set a review date, outcome measure and stop or change plan. Explain the medicine. State purpose, expected time to benefit, common effects, warning symptoms, missed-dose advice, interactions, alcohol advice, pregnancy advice and how to contact the service. 2. Pharmacodynamic and pharmacokinetic essentials Concept Clinical meaning Receptor action Agonism, antagonism, partial agonism, reuptake inhibition and ion-channel effects explain both benefit and adverse effects. Half-life Determines time to steady state, dosing frequency and how long interactions or withdrawal may last. Therapeutic window Lithium and some anticonvulsants require serum levels because the dose producing benefit may be close to the dose producing toxicity. First-pass and metabolism Liver enzyme inhibition or induction changes concentrations of medicines and contraceptives; smoking induces CYP1A2 and can lower clozapine or olanzapine levels. Adherence and formulation Daily tablets, liquid, dispersible, depot or long-acting injection have different practical advantages and safety requirements. 3. Antidepressants Antidepressants are used for depressive disorders and selected anxiety, obsessive-compulsive, trauma-related, pain and eating disorders. They are not substitutes for risk management, psychosocial support or treatment of bipolar mania. Always ask about previous mania or hypomania, psychosis, substance use, suicide risk and medical causes before prescribing. 3.1 Selective serotonin reuptake inhibitors (SSRIs) Examples: sertraline, fluoxetine, escitalopram, citalopram, paroxetine and fluvoxamine. Mechanism: inhibit the serotonin transporter, increasing synaptic serotonin over time. Therapeutic improvement may begin after 2–4 weeks; full benefit can take longer. Indications: depression, panic disorder, social anxiety, generalised anxiety, obsessive-compulsive disorder, PTSD and some eating disorders, depending on guideline and indication. Common effects: nausea, diarrhoea, headache, insomnia or somnolence, sweating, tremor, sexual dysfunction and initial anxiety or restlessness. Serious risks: suicidal thoughts or activation in younger patients, serotonin syndrome, hyponatraemia, bleeding, QT prolongation with citalopram, mania switch and discontinuation symptoms. Medicine Typical adult educational range High-yield cautions Sertraline Start 25–50 mg once daily; usual 50–200 mg/day Often useful when cardiac risk or multiple conditions are present; monitor activation, GI effects and sexual dysfunction. Fluoxetine Start 10–20 mg once daily; usual 20–60 mg/day Long half-life; fewer discontinuation symptoms but interactions may persist for weeks. Activating and a strong enzyme inhibitor. Escitalopram Start 5–10 mg once daily; usual 10–20 mg/day Dose and QT precautions in older adults, hepatic disease or cardiac risk. Citalopram Start 10–20 mg once daily; usual 20–40 mg/day QT prolongation is dose-related; avoid with significant QT risk and review interacting medicines. Paroxetine Start 10–20 mg once daily; usual 20–50 mg/day Anticholinergic and sexual effects; prominent withdrawal; pregnancy and interaction review essential. Fluvoxamine Start 50 mg at night; titrate commonly to 100–300 mg/day Many CYP interactions; commonly used for OCD rather than routine first-line depression. 3.2 Serotonin–noradrenaline reuptake inhibitors (SNRIs) Venlafaxine inhibits serotonin and noradrenaline reuptake in a dose-related manner. A common educational regimen is 37.5–75 mg/day initially, titrated to 75–225 mg/day. Monitor blood pressure, pulse, agitation, sexual effects, withdrawal and serotonin toxicity. Overdose may cause seizures, arrhythmia and severe toxicity. Duloxetine is commonly started at 30 mg/day and increased to 60 mg/day; some indications use up to 120 mg/day. It may benefit neuropathic pain but requires caution in significant liver disease, heavy alcohol use, uncontrolled hypertension and interactions. 3.3 Tricyclic antidepressants (TCAs) Amitriptyline, imipramine, clomipramine and nortriptyline block serotonin/noradrenaline reuptake but also antagonise muscarinic, histamine and alpha-1 receptors. They can be effective but are more dangerous in overdose. Indications: selected depression, OCD (especially clomipramine), neuropathic pain and migraine prevention depending on local guidance. Typical educational dosing: amitriptyline 25 mg at night, titrated cautiously (often 75–150 mg/day for depression; lower doses for pain); clomipramine 25 mg/day, titrated according to indication and specialist monitoring. Adverse effects: dry mouth, blurred vision, constipation, urinary retention, tachycardia, postural hypotension, sedation, weight gain, sexual dysfunction, seizures and arrhythmia. Contraindications/cautions: recent myocardial infarction, significant conduction disease, uncontrolled glaucoma, urinary retention, severe constipation, high suicide or overdose risk and interaction with MAOIs. Overdose emergency: wide QRS, hypotension, seizures, coma and ventricular arrhythmia require emergency toxicology management; do not manage with routine psychiatric observation. 3.4 Other antidepressants Mirtazapine: noradrenergic and specific serotonergic antidepressant. Start commonly at 15 mg

Clinical Medicine Year 2 • Mental Health Care Relevant Psychiatric and Psychosocial Investigations: A Complete Clinical Guide Relevant psychiatric and psychosocial investigations are the targeted bedside assessments, laboratory tests, imaging studies, screening instruments and social enquiries used to clarify a mental-health presentation, identify a reversible medical or substance-related cause, establish treatment safety, assess risk and plan recovery. A good investigation plan is not a request for every available test. It is a reasoned response to the patient’s history, mental state examination, physical findings, age, medication exposure, risk and local epidemiology. Safety first: A patient with an abnormal vital sign, hypoglycaemia, hypoxia, severe intoxication or withdrawal, seizure, head injury, fever, meningism, severe agitation, reduced consciousness or suspected overdose needs emergency medical assessment before a routine psychiatric work-up. Do not label a fluctuating or medically unwell patient as having a primary psychiatric disorder until urgent physical causes have been considered. Learning objectives By the end of this guide, the learner should be able to: Explain why most primary psychiatric disorders are clinical diagnoses rather than diagnoses made by a single laboratory test. Choose immediate bedside observations, physical examinations and focused investigations according to the presentation. Recognise red flags for delirium, first-episode psychosis, new-onset mania, cognitive decline, catatonia, seizures and substance-related emergencies. Use screening and symptom-rating instruments without confusing a score with a diagnosis or risk decision. Complete a culturally sensitive psychosocial assessment, including collateral history, functioning, safeguarding, capacity and social determinants of health. Document the clinical question, result, interpretation, action and follow-up for every investigation. 1. The central principle: investigate the patient, not the label Psychiatric assessment starts with the patient’s story, collateral information, risk assessment, physical examination and mental state examination. Investigations answer specific questions: Clinical question Examples of useful investigations What the result changes Could this be immediately life-threatening? Airway, breathing and circulation observations, capillary glucose, oxygen saturation, temperature, ECG, pregnancy test, targeted toxicology Resuscitation, observation level, antidote, medical admission or urgent referral Could a medical or neurological condition explain the symptoms? Focused blood tests, urinalysis, infection tests, neurological examination, CT/MRI, EEG or lumbar puncture when indicated Diagnosis, treatment of the underlying illness and medical rather than psychiatric placement Is the patient safe to receive a proposed medicine? Weight/BMI, blood pressure, pulse, ECG, renal and liver function, pregnancy status, blood count, glucose/HbA1c and lipids; drug levels when appropriate Choice of medicine, dose, contraindications, monitoring and consent What is the current symptom burden? PHQ-9, GAD-7, PTSD measures, YMRS, PANSS, MoCA/MMSE, 4AT or CAM, alcohol and drug screens Baseline severity, communication and monitoring of response What is needed for recovery and safe discharge? Function, housing, finances, family/caregiver capacity, safeguarding, violence exposure, substance use, school or work, transport and access to care Care plan, social interventions, referrals, follow-up and relapse prevention High-yield rule There is no blood test that confirms “depression,” “schizophrenia” or “bipolar disorder” in isolation. Tests are used to find mimics, comorbidity, treatment risks and complications. A normal panel never excludes a psychiatric disorder, and an abnormal result must be interpreted in clinical context. 2. A practical investigation sequence Stabilise and triage. Assess airway, breathing, circulation, disability, exposure, consciousness, agitation, violence risk, self-harm risk and immediate access to dangerous means. Repeat vital signs and bedside measures. Record temperature, pulse, blood pressure, respiratory rate, oxygen saturation, capillary glucose, level of consciousness, pain and hydration status. Repeat abnormal observations. Take a complete history and collateral history. Establish onset, time course, baseline function, medications, substances, medical and neurological illness, pregnancy possibility, trauma, psychosocial stressors and previous episodes. Perform a focused physical and neurological examination. Look for infection, endocrine disease, intoxication or withdrawal, focal neurological signs, head trauma, malnutrition, movement disorder and medication toxicity. Define the clinical question. Do not order a test merely because it is customary. State what you are looking for and what action will follow a positive or negative result. Order targeted investigations. Select bedside tests, blood tests, toxicology, ECG, imaging or specialist investigations according to risk and findings. Interpret, act and communicate. Document the result, significance, action, responsible clinician and time for review. A test that is ordered but not acted upon is an unsafe investigation. 3. Immediate bedside assessment and physical examination 3.1 Observations that should not be missed Temperature: fever suggests infection, inflammatory disease, serotonin toxicity, neuroleptic malignant syndrome or severe withdrawal; hypothermia may occur in exposure, endocrine failure, intoxication or sepsis. Pulse and blood pressure: tachycardia, hypertension, hypotension or postural change may indicate intoxication, withdrawal, dehydration, sepsis, pain, mania, medication effects or autonomic instability. Respiratory rate and oxygen saturation: detect opioid or sedative respiratory depression, pneumonia, asthma, pulmonary disease and metabolic decompensation. Capillary blood glucose: perform early in altered behaviour, confusion, collapse, seizure, reduced consciousness, diabetes, suspected overdose or poor oral intake. Level of consciousness and attention: reduced arousal or impaired attention strongly raises concern for delirium, intoxication, withdrawal, seizure or an encephalopathy. Weight, BMI and waist circumference: provide a baseline before and during antipsychotic treatment and identify malnutrition or metabolic risk. Pregnancy status: ask privately and respectfully where pregnancy is possible before radiation, valproate, lithium or other potentially teratogenic treatment. 3.2 Focused physical examination General appearance: hydration, pallor, jaundice, cyanosis, odour of alcohol or chemicals, nutritional state, self-care and evidence of neglect. Neurological examination: pupils, speech, cranial nerves, power, tone, reflexes, sensation, coordination, gait, tremor, rigidity, clonus and involuntary movements. Signs of head injury: scalp injury, periorbital bruising, vomiting, amnesia, seizure or focal deficit. Endocrine clues: thyroid enlargement, tremor, heat or cold intolerance, weight change, hyperpigmentation, proximal weakness or Cushingoid features. Infection and inflammation: fever, meningism, rash, focal infection, lymphadenopathy, HIV-related illness or tuberculosis symptoms. Medication effects: akathisia, parkinsonism, dystonia, tardive movements, sedation, orthostatic hypotension, anticholinergic signs, bruising, jaundice and lithium tremor. Trauma and safeguarding: bruises, burns, genital injury, fractures or injuries inconsistent with the history require a safe, non-accusatory safeguarding response. 4. Core laboratory investigations There is no universal psychiatric panel. A reasonable baseline set depends on the presentation, age, comorbidity, medication plan and available resources. In a new or medically unexplained presentation, consider

Clinical focus: The Mental State Examination (MSE) is a structured description of how a patient appears, behaves, speaks, feels, thinks, perceives and functions cognitively at one point in time. It is not a diagnosis by itself. Record observable facts, the patient’s words and clinically relevant inferences separately, while considering culture, language, disability, medical causes and safety. Learning objectives Conduct and document a complete MSE in a respectful, culturally sensitive manner. Distinguish mood from affect, thought form from thought content and hallucination from illusion. Assess cognition, insight, judgement and capacity without using vague labels. Link MSE findings to risk, differential diagnosis, delirium and the management plan. Write concise normal and abnormal MSE examples suitable for emergency and ward notes. 1. Preparing for the MSE Confirm immediate medical stability, glucose, intoxication/withdrawal and delirium risk before relying on psychiatric interpretation. Introduce yourself, obtain consent, explain confidentiality limits and use a trained interpreter when required. Observe from the moment the patient enters, but do not stare or make the patient feel watched. Consider culture, language, education, age, hearing/vision, neurodevelopmental differences, pain and medication effects. Maintain safety: do not interview alone when there is imminent violence, severe agitation or self-harm risk. 2. MSE domains at a glance Domain Core question Example wording Appearance What does the patient look like? “Clean, appropriately dressed, clothing dishevelled, multiple healed scars on forearms.” Behaviour/psychomotor activity How does the patient relate and move? “Cooperative, guarded, pacing, tremulous, responding to unseen stimuli.” Speech How is communication produced? “Rapid, loud and difficult to interrupt” or “soft, slowed, long latency.” Mood What does the patient say they feel? “Mood ‘empty and hopeless’.” Affect What emotion is observed? “Restricted, anxious, reactive, congruent/incongruent with stated mood.” Thought form How are ideas connected? “Linear and goal-directed” or “flight of ideas, loosening of associations.” Thought content What beliefs, worries and impulses are present? “Persecutory delusion; passive death wish; no plan disclosed.” Perception Are sensory experiences altered? “Third-person auditory hallucinations; no visual hallucinations reported.” Cognition Is attention, orientation and memory intact? “Alert, distractible, oriented to person/place but not date.” Insight/judgement Does the patient understand and make safe decisions? “Partial insight; recognises distress but rejects need for treatment.” 3. Appearance and behaviour Appearance: grooming, hygiene, clothing, appropriateness to weather/context, nutrition, posture, eye contact, tattoos/scars/injuries and signs of intoxication or withdrawal. Describe rather than judge (“strong odour of alcohol,” not “dirty”). Attitude: cooperative, open, guarded, suspicious, hostile, withdrawn, seductive, disinhibited or fearful. Consider whether language or trauma explains apparent guardedness. Psychomotor activity: normal, agitation, pacing, retardation, catatonic features, tremor, tics, abnormal movements or akathisia. Engagement: rapport, response to reassurance, ability to remain seated, eye contact and response to internal stimuli. 4. Speech and language Document rate, volume, tone, quantity, fluency, spontaneity, latency, articulation and interruptibility. Rapid pressured speech with reduced need for sleep may suggest mania; slowed low-volume speech may occur in depression, medication effect or neurological disease. Poverty of speech may reflect psychosis, depression, language barrier or cognitive impairment. Use an interpreter and record language factors. 5. Mood and affect Mood is the patient’s sustained internal emotional state (“How have you been feeling?”). Affect is the clinician’s observation of emotional expression. Affect descriptor Meaning Range Broad/full, restricted, blunted or flat. Intensity Normal, heightened, reduced or labile. Reactivity Changes appropriately with conversation or remains fixed. Stability Stable or rapidly shifting/labile. Congruence Matches or differs from stated mood and thought content. Culture, trauma, neurodiversity and communication style influence emotional expression. A smiling patient may still be depressed; a restricted affect does not prove psychosis. 6. Thought form and thought process Finding Definition/example Possible associations Linear/goal-directed Ideas follow a coherent path to an answer. Typical organisation. Tangential Moves away from the question and does not return. Psychosis, mania, cognitive disorder. Circumstantial Excessive detail but eventually reaches the point. Anxiety, personality style, cognitive change. Flight of ideas Rapid shifts with understandable links, often pressured speech. Mania. Loose associations Weak or unclear connections between ideas. Psychosis, delirium, neurological disease. Thought blocking Sudden interruption with loss of the train of thought. Psychosis, anxiety, seizures. Perseveration Inappropriately repeats a response or theme. Frontal/neurological disorder, delirium. Incoherence/word salad Speech cannot be understood as a meaningful sequence. Severe psychosis, delirium or neurological illness. 7. Thought content and risk Ask sensitively about beliefs, worries, obsessions, compulsions, guilt, hopelessness, grandiosity, passivity, suicidal thoughts, homicidal thoughts and command hallucinations. Delusion: fixed belief not shared by the cultural/religious context and not amenable to evidence; describe theme, conviction, preoccupation, distress and behaviour. Overvalued idea: strongly held idea that may be understandable and less fixed than a delusion. Obsession: intrusive, unwanted, recurrent thought/image/urge; ask about compulsions and insight. Suicidal thinking: passive wish, active thoughts, intent, plan, preparation, access to means, previous attempts and protective factors. Command hallucination: ask what the voice says, whether the patient feels compelled, target, intent and ability to resist. Never write “no risk” without documenting what was asked and observed. Risk is dynamic and requires a plan. 8. Perception Hallucination: perception without an external stimulus; ask modality, content, frequency, distress, commands, insight and relationship to sleep/substances. Illusion: misinterpretation of a real stimulus, common in delirium, anxiety or low light. Pseudohallucination/dissociation: terms require careful description of the patient’s experience rather than assumption. Assess hearing/vision impairment, fever, epilepsy, substances, medication, sleep deprivation and neurological signs before diagnosing a primary psychosis. 9. Cognition Assess alertness, attention, orientation, memory, language, visuospatial function and executive ability as clinically indicated. Domain Examples of bedside assessment Attention Digit span, months backwards, serial subtraction or ability to follow a conversation. Orientation Person, place, date/time and situation; document the exact errors. Registration/recall Repeat and later recall three words, considering language/education. Language Naming, repetition, comprehension, fluency and literacy; distinguish aphasia from limited language proficiency. Executive function Abstraction, planning, set-shifting or similarities/proverbs adapted to culture. Fluctuation Variation in attention/arousal over minutes-hours suggests delirium. Formal tools such as MoCA, MMSE, 4AT or CAM can support assessment but do not replace history, examination and collateral information. Adjust for language, hearing, vision, education and cultural familiarity. 10. Insight, judgement and capacity Insight: awareness

Clinical focus: Psychiatric history taking is a structured, empathic clinical interview. It establishes the patient’s story, symptoms, functioning, medical and substance contributors, risks, strengths and goals. It is not an interrogation or a substitute for physical examination; urgent safety and delirium assessment come first. Learning objectives Build a therapeutic alliance and conduct a confidential, culturally safe interview. Structure the psychiatric clerking from presenting complaint to formulation and plan. Characterise symptoms by onset, duration, severity, course, triggers, function and associated features. Assess suicide, violence, abuse, neglect, vulnerability, psychosis, substances and medical emergencies. Obtain collateral history ethically and formulate biological, psychological and social contributors. 1. Preparation and engagement Ensure privacy, safety, adequate time, seating at eye level and a chaperone/interpreter when appropriate. Introduce yourself, confirm identity, explain confidentiality and its limits (imminent risk, safeguarding and lawful reporting). Ask how the patient would like to be addressed and whether they want a support person present. Start with an open invitation: “What has brought you in today?” Avoid premature diagnostic labels. Assess capacity to participate; if the patient is severely agitated, intoxicated, delirious or unsafe, stabilise and obtain help before a full interview. 2. Psychiatric clerking structure Section Essential content Identifying information Name, age, gender, residence, occupation/school, relationship, informant and reliability. Presenting complaint Patient’s words and duration; record the reason for referral. History of presenting illness Timeline, symptom domains, severity, triggers, function, treatment, risks and patient perspective. Past psychiatric history Diagnoses, episodes, admissions, therapies, self-harm, violence, response, adherence and adverse effects. Medical/neurological history Illnesses, head injury, seizures, endocrine disease, pain, infections, pregnancy, medications and allergies. Substance history Alcohol, tobacco, cannabis, stimulants, opioids, sedatives, khat/other local substances, prescribed and traditional medicines. Personal/developmental history Pregnancy/birth, milestones, education, relationships, trauma, work, legal/financial stressors and strengths. Family history Mental illness, suicide, substance use, neurological/genetic illness, violence and support. Social/forensic history Housing, finances, dependants, safety, legal issues, violence, weapons, migration and services. Mental state examination Appearance, behaviour, speech, mood/affect, thought, perception, cognition, insight and judgement. Risk assessment Self-harm, harm to others, vulnerability, neglect, abuse, absconding, command hallucinations and access to means. Formulation/plan Biopsychosocial formulation, differential, investigations, immediate safety, treatment and follow-up. 3. History of the presenting illness Build a chronological narrative. Begin with the patient’s own account, then clarify. Dimension Questions Onset/course When did it start? Sudden or gradual? First episode or recurrent? Continuous, episodic or fluctuating? Precipitants Loss, trauma, conflict, illness, medication, substance, sleep deprivation, pregnancy/postpartum or legal/financial stress? Severity/function What can the patient no longer do? Work, school, self-care, relationships, eating, sleep or finances? Associated mood Sadness, anhedonia, irritability, guilt, hopelessness, elevated/expansive mood, reduced need for sleep or impulsivity. Anxiety/trauma Excessive worry, panic, avoidance, intrusive memories, nightmares, hyperarousal or dissociation. Psychosis Hearing/seeing things, beliefs others do not share, thought interference, disorganisation and command content. Cognition Attention, memory, orientation and fluctuation; ask family about change from baseline. Somatic/vegetative Sleep, appetite, energy, libido, pain, weight, autonomic symptoms and menstrual/pregnancy changes. Treatment response What has been tried, dose/duration/adherence, benefit, adverse effects and barriers? 4. Risk assessment: ask directly and calmly Suicide and self-harm “Have you wished you were dead or thought life was not worth living?” “Have you had thoughts of killing yourself, a plan, intent or access to the means?” “Have you taken steps, rehearsed, written a note or made preparations?” Previous attempts, recent discharge, severe pain, intoxication, psychosis, agitation, losses and access to pesticides/firearms/medicines increase concern. Protective factors include relationships, responsibilities, beliefs, future goals and willingness to accept help—but never assume they cancel an active plan. Harm to others and vulnerability Ask about thoughts, target, intent, plan, access to weapons, command hallucinations, domestic violence, abuse, neglect, exploitation, homelessness, inability to eat/drink, wandering and unsafe dependence. A high-risk patient should not be left alone; involve senior staff, family only with consent/safety consideration, and emergency services according to law. 5. Past psychiatric and treatment history Age at first symptoms, number/duration of episodes, triggers, inter-episode recovery and previous diagnoses. Admissions, emergency visits, restraints, ECT, psychotherapy, traditional/faith support, community care and rehabilitation. Medication name, dose, timing, duration, adherence, therapeutic response, adverse effects, interactions, pregnancy and abrupt withdrawal. Past self-harm, suicide attempts, aggression, violence, safeguarding involvement and legal orders. What the patient found helpful or harmful; record their goals and preferences. 6. Medical, neurological and medication review New psychiatric symptoms can be caused or worsened by physical illness. Ask about thyroid/adrenal disease, diabetes/hypoglycaemia, epilepsy, head injury, stroke, HIV/syphilis or other infection, autoimmune disease, liver/renal failure, pain, sleep disorders, pregnancy/postpartum state and menopause. Medication/exposure Possible psychiatric effect Corticosteroids Insomnia, mood elevation, depression or psychosis. Dopaminergic drugs/stimulants Agitation, insomnia, mania or psychosis. Anticholinergics/opioids/sedatives Confusion, memory impairment, delirium or falls. Thyroid medicines, interferon, some antimalarials Mood, anxiety, sleep or psychotic symptoms in susceptible patients. Withdrawal from alcohol/benzodiazepines Tremor, autonomic instability, seizures, hallucinations and delirium. 7. Substance-use history: non-judgemental detail Ask about each substance separately: name, amount, frequency, route, timing, last use, cravings, tolerance, loss of control, consequences, attempts to stop, withdrawal, overdose, injecting/needle sharing and readiness to change. Include alcohol quantity in standard drinks when possible, tobacco/nicotine, cannabis, stimulants, opioids, sedatives, inhalants, prescription drugs and local substances. Do not diagnose intoxication or withdrawal from behaviour alone. Check glucose, vital signs, temperature, oxygenation and neurological status, and consider toxicology or withdrawal scales according to local protocol. 8. Personal, developmental and social history Pregnancy/birth complications, developmental milestones, childhood illnesses and school performance. Attachment, caregivers, education, friendships, relationships, sexuality, identity and experiences of discrimination. Trauma, violence, sexual abuse, neglect, displacement, imprisonment or occupational exposure—ask with permission and do not force details before safety is established. Employment, finances, housing, food security, caregiving, transport, legal issues and access to medicines. Culture, language, faith, explanatory model, traditional healers and community resources. Strengths, coping strategies, goals and people the patient trusts. 9. Family history and collateral information Ask about depression, bipolar disorder, psychosis, suicide, substance use, dementia, epilepsy, developmental disorders and relevant medical/genetic illness. With consent and explanation, collateral history can clarify baseline function, sleep, medication adherence, safety and fluctuating cognition. If the patient lacks capacity or immediate risk exists, share only

Clinical focus: Mental health is part of health across the lifespan, not simply the absence of mental illness. This introduction links well-being, mental disorders, social determinants, culture, stigma, prevention and the role of primary-care clinicians. It uses WHO mhGAP principles and should be adapted to Ugandan law, policy, referral resources and cultural context. Learning objectives Define mental health, mental well-being, mental disorder, distress, disability, recovery and psychosocial support. Describe biological, psychological, social, cultural, structural and environmental determinants of mental health. Recognise common mental-health presentations and urgent red flags in primary care. Challenge myths and stigma while preserving safety, dignity, human rights and confidentiality. Explain prevention, promotion, early identification, stepped care and the WHO mhGAP approach. 1. What is mental health? Mental health is a state of well-being that enables a person to cope with life’s stresses, learn and work, build relationships, make decisions and participate in community life. It exists on a continuum and changes with age, health, trauma, relationships and circumstances. A person can live with a mental disorder and still experience recovery, purpose and meaningful participation; a person without a diagnosable disorder can still experience severe distress. Term Meaning Clinical implication Mental well-being Emotional, psychological, social and relational functioning that supports meaning and participation. Promote strengths and functioning, not only symptoms. Mental distress Subjective suffering or difficulty coping, which may be transient or severe. Listen and assess risk without automatically assigning a diagnosis. Mental disorder/condition A clinically significant disturbance in cognition, emotion regulation or behaviour with distress, impairment or risk; definitions require context and duration. Use a structured assessment and consider medical/substance causes. Psychosocial disability Functional limitation arising from interaction between a mental condition and environmental barriers/attitudes. Assess reasonable accommodation, support and rights. Recovery Personal process of living a meaningful life, with or without ongoing symptoms. Set collaborative goals; avoid therapeutic pessimism. Psychosocial support Social, emotional and practical assistance that strengthens coping and functioning. Offer family/community support, problem-solving and referral alongside medicine. 2. Mental health across the lifespan Infancy/childhood: attachment, development, play, language, behaviour, learning and safety. Developmental variation is not automatically disorder. Adolescence: identity, peer relationships, school stress, substance exposure, self-harm, eating problems and violence risk. Adults: work, relationships, pregnancy/postpartum, chronic disease, trauma, caregiving, substance use and economic stress. Older adults: bereavement, isolation, dementia, delirium, polypharmacy, pain, sensory loss and medical illness. Symptoms and help-seeking are shaped by language, gender, culture, faith, disability, sexuality, poverty and access. Ask what the person thinks is happening and what support they prefer. 3. Determinants of mental health Level Examples Protective or harmful pathway Biological Genetics, brain development, sleep, hormones, neurological disease, infection, pain and medication Altered neurobiology may increase vulnerability; treatment and healthy sleep can protect. Psychological Temperament, coping, trauma, cognition, emotion regulation and self-esteem Adaptive coping buffers stress; trauma and hopelessness increase risk. Family/relationship Attachment, violence, caregiving, loss, social support and belonging Safe relationships protect; abuse and isolation harm. Community School/work, housing, food security, transport, discrimination and social cohesion Stable resources support participation; deprivation creates chronic stress. Structural Poverty, conflict, displacement, gender inequality, laws, stigma and health-system access Social determinants shape exposure, opportunities and ability to obtain care. 4. Mental health and physical health Mental and physical health are bidirectional. Depression can reduce adherence and activity; diabetes, HIV, epilepsy, thyroid disease, anaemia, chronic pain, stroke and medication effects can produce or worsen psychiatric symptoms. Always assess both domains. New confusion, fluctuating attention, fever, head injury, seizures, hypoglycaemia, hypoxia or intoxication suggests a medical emergency such as delirium until proven otherwise. Depression and psychosis can present with somatic complaints, while cardiac, endocrine and neurological disease can mimic panic or mood symptoms. Ask about sleep, nutrition, substance use, pregnancy/postpartum status, prescribed medicines and traditional/herbal remedies. 5. Common presentations in primary care Presentation Examples First assessment question Low mood/anhedonia Depression, grief, adjustment, medical illness Duration, functioning, sleep/appetite, hopelessness and self-harm thoughts. Anxiety/fear Generalised anxiety, panic, trauma, medical/substance cause Triggers, physical symptoms, avoidance, safety and stimulant/substance use. Altered behaviour/perception Psychosis, mania, intoxication, delirium, neurological disease Onset, attention/orientation, sleep, substances, medications and immediate risk. Cognitive decline Dementia, delirium, depression, sensory impairment Time course, fluctuation, function, medication and collateral history. Self-harm/suicidality Thoughts, plans, intent, access to means, previous attempts Ask directly and privately; ensure immediate safety. Substance-related Alcohol, opioids, stimulants, sedatives and withdrawal Substances used, amount, timing, route, dependence and withdrawal risk. 6. A respectful mental-health assessment Engage: introduce yourself, ensure privacy and explain confidentiality and its safety limits. Presenting concern: ask “What brings you today?” and listen without premature labelling. Symptoms and course: onset, duration, severity, triggers, functioning, sleep, appetite, energy and cognition. Risk: suicide/self-harm, harm to others, abuse, neglect, vulnerability, command hallucinations, access to weapons/poisons and inability to care for self. Medical/substance screen: medications, medical disease, pregnancy, substances, withdrawal and delirium. Context and strengths: family/community supports, culture/faith, housing, income, goals, coping and previous helpful care. Shared plan: immediate safety, psychosocial interventions, tests/referral, follow-up and crisis contacts. 7. Mental status examination (introduction) Domain What to observe/ask Appearance/behaviour Grooming, posture, eye contact, psychomotor agitation/retardation, cooperation and abnormal movements. Speech Rate, volume, fluency, latency, pressure, poverty or dysarthria. Mood/affect Patient’s described mood; observed range, reactivity, congruence and stability. Thought form Logical/goal-directed versus flight of ideas, loosening, tangentiality or thought blocking. Thought content Worries, guilt, hopelessness, delusions, obsessions, suicidal/homicidal thoughts and command content. Perception Hallucinations, illusions, dissociation and sensory impairment. Cognition Attention, orientation, memory, language, executive function and insight. Insight/judgement Understanding of illness, choices, consequences and ability to engage safely. 8. Stigma, discrimination and human rights Stigma can delay help-seeking, reduce adherence, harm employment and relationships, and expose people to violence or neglect. Use person-first language, ask permission before involving family, and never equate a diagnosis with dangerousness or incapacity. People have rights to dignity, informed consent, least-restrictive care, confidentiality, communication support and participation in decisions, subject to lawful safety exceptions. Restraint and seclusion are last-resort safety interventions, not punishment; follow law, policy, monitoring and documentation requirements. Traditional and faith-based support may be meaningful; collaborate safely and intervene when practices cause harm or delay emergency care.

Concepts of Disease: Illness, Sickness and the Clinical Meaning of Health Doctors do not treat laboratory results alone. They treat people who experience symptoms, interpret them through culture, and live with illness in families, workplaces and communities. The concepts of disease, illness and sickness provide a practical framework for history-taking, diagnosis, communication and ethical care. Key distinction: disease is the clinician’s formulation of pathology; illness is the patient’s lived experience of symptoms and suffering; sickness is the social role, expectations and consequences attached to being unwell. 1. Health, disease, illness and sickness Health is more than the absence of a named disease. It includes functional ability, participation, mental wellbeing and the ability to adapt to changing circumstances. Disease refers to abnormal structure or function identified through clinical reasoning, examination, investigations or recognised criteria. Illness includes pain, fatigue, fear, uncertainty and loss of normal activities. Sickness describes how family, employers, schools and communities respond to the person. 2. Why the distinction matters A patient may have disease without feeling ill, as in hypertension or early kidney disease. A patient may feel ill without a detectable structural lesion, as in many functional disorders. A patient can have severe social consequences despite mild pathology. A patient can carry a diagnosis but remain healthy in daily function. Failure to distinguish these concepts can lead to dismissing symptoms, over-testing, stigma or treatment plans that ignore what the patient needs to resume life. 3. Biomedical model The biomedical model explains disease through anatomy, physiology, pathology, infection, genetics, pharmacology and measurable mechanisms. It is essential for recognising emergencies and selecting effective treatment. Its limitation is reductionism: a test result may identify a mechanism without explaining why the illness began, why the patient delayed care, or what makes adherence possible. 4. Biopsychosocial model The biopsychosocial model integrates biological processes with emotions, behaviour, relationships, income, housing, work, education and culture. It does not mean that every disease is psychological. It means that every patient experiences disease in a body, mind and social environment. Clinical application For a patient with asthma, assess airway inflammation and inhaler technique, but also smoke exposure, housing, cost, health literacy, anxiety, work and ability to return for review. 5. Explanatory models of illness Patients and clinicians may use different explanations. Ask: What do you call the problem? What do you think caused it? Why did it begin now? What does it do? How severe is it? What treatment do you expect? What worries you most? Explanatory models may include infection, heredity, stress, food, pollution, spiritual causes, social conflict or traditional concepts of imbalance. 6. Symptoms, signs, syndromes and diagnoses Symptom: a subjective experience such as pain, dizziness or breathlessness. Sign: an observable or measurable finding such as fever, pallor or a murmur. Syndrome: a recognisable cluster of symptoms and signs. Diagnosis: a reasoned conclusion about the cause or nature of illness. Do not convert a symptom into a disease label prematurely. Use working diagnoses, state uncertainty and safety-net the patient. 7. Acute, chronic, recurrent and terminal illness Acute illness develops over a short period and may resolve, worsen rapidly or reveal chronic disease. Chronic illness persists and requires monitoring, prevention, rehabilitation and adaptation. Recurrent illness returns after improvement. Terminal illness involves progressive disease where goals may shift toward comfort, dignity and support. Explain the expected course honestly but compassionately. 8. Functional and medically unexplained symptoms Normal routine tests do not prove that symptoms are imaginary. Functional disorders involve altered regulation or processing of body systems, and psychological stress may amplify symptoms without making them unreal. Validate the experience, examine for red flags, explain the positive features supporting the diagnosis, avoid endless testing and arrange follow-up. 9. Pain and suffering Pain is a sensory and emotional experience influenced by tissue injury, nervous-system processing, fear, previous experience, sleep, culture and social support. Suffering is broader: it includes threat to identity, family role, future and dignity. Assess severity, function, meaning, risk of substance harm and the patient’s goals. 10. Behaviour, adherence and self-management Non-adherence is not a diagnosis of laziness. Explore cost, side effects, instructions, beliefs, transport, stigma, depression, memory, competing priorities and whether the treatment seems to work. Simplify regimens, use teach-back and agree on measurable actions. 11. Stigma and diagnostic labels Labels can unlock treatment but can also cause shame, discrimination, family rejection or loss of employment. HIV, tuberculosis, epilepsy, infertility, mental illness, obesity, substance use and cancer may be stigmatised. Use person-first language, protect confidentiality and ask how the diagnosis affects the patient’s relationships and safety. Never equate illness with moral failure. Addiction, obesity, sexually transmitted infection, mental illness and treatment delay require clinical assessment and support, not blame. 12. Culture, spirituality and traditional care Patients may combine biomedical treatment with prayer, herbal remedies, family advice or traditional healing. Ask without ridicule what has been used, the ingredients, dose, timing and perceived effect. Identify interactions and dangerous delay. Respect beliefs while clearly recommending urgent care when life or organ function is at risk. 13. The sick role Being sick can temporarily excuse normal duties and create an expectation of care, but the role differs by family and culture. Some people gain support; others are blamed, abandoned or expected to keep working. Ask about work, caregiving, finances, transport and who can help with medicines. 14. Diagnostic uncertainty and probability Early consultations often produce a differential diagnosis rather than certainty. Explain what is most likely, what dangerous alternatives are being excluded, what test results mean, and when the plan will change. Avoid false reassurance, but do not communicate every remote possibility in a way that causes unnecessary fear. 15. Doctor–patient relationship Trust improves disclosure and shared decisions. Introduce yourself, confirm identity, obtain consent, listen without interruption, summarise, acknowledge emotion and check understanding. Shared decision-making includes the best evidence, clinical expertise and patient values. 16. Practical consultation framework Clarify the patient’s main concern and functional impact. Explore the patient’s explanatory model and expectations. Assess biological danger signs and psychosocial risk. Explain the working diagnosis and uncertainty in

Culture and Its Impact on Health and Healthcare Culture is the shared system of meanings, values, beliefs, language, practices and social relationships through which people understand life, illness, healing and death. Culture does not determine every decision, but it strongly influences how people explain symptoms, seek help, communicate distress, use food and medicines, and relate to health professionals. Learning objectives Define culture and health; explain cultural influences on illness beliefs and health behaviour; describe explanatory models, ethnomedicine, language and stigma; identify risks of cultural stereotyping; and provide culturally safe, respectful and clinically effective care. 1. Culture, society and health Culture is learned, shared, transmitted and adapted. It includes visible practices such as food, dress and ceremonies, and less visible assumptions about the body, family, gender, time, authority, pain and responsibility. A patient may belong to several cultural groups at once, including family, ethnic, religious, professional, generational and online communities. 2. Cultural concepts of health and illness Different communities may understand health as balance, strength, social harmony, spiritual protection, fertility, ability to work or freedom from symptoms. Illness may be explained through infection, heredity, environment, stress, social conflict, ancestors, spiritual causes or a combination. A doctor’s task is not to ridicule the explanation but to understand it, identify danger and build a safe treatment plan. 3. Explanatory models An explanatory model is the patient’s or family’s answer to: What is the problem called? What caused it? Why did it start now? What does it do? How serious is it? What treatment should be used? What is expected to happen? Asking these questions reveals beliefs that may affect consent and adherence. Area to explore Useful question Clinical value Cause “What do you think caused this problem?” Identifies beliefs, guilt, stigma and possible exposures. Expected treatment “What treatment were you hoping for?” Reveals expectations and opportunities for negotiation. Previous help “What have you already tried?” Prevents unsafe duplication and improves trust. Family meaning “Who else is concerned or involved?” Shows support, pressure and decision-making roles. Preferred explanation “How much detail would you like today?” Respects autonomy and information preferences. 4. Language and communication Language affects symptom description, consent, risk communication and safety-netting. Translation is not only word substitution; idioms, metaphors and culturally specific meanings matter. Use a trained interpreter when necessary, speak to the patient rather than the interpreter, use short sentences and confirm understanding with teach-back. Do not use children as interpreters for sensitive or complex information. 5. Pain, distress and emotional expression Culture may influence whether pain is openly expressed, minimised, attributed to a social or spiritual problem, or communicated through bodily symptoms. Avoid assuming that quietness means little pain or that dramatic expression means exaggeration. Combine the patient’s report with examination, function and risk assessment. 6. Food, diet and healing Food practices may be linked to identity, religion, pregnancy, illness, age and household roles. Some restrictions may cause malnutrition; others may support health. Ask what the patient eats, avoids, can afford and believes is therapeutic. Dietary counselling should be culturally acceptable, locally available and compatible with medical goals. 7. Family, gender and decision-making Some patients expect collective decisions; others expect individual privacy. Gender and age may determine who controls money, speaks for the family or gives permission. Respect the patient’s autonomy while safely involving relatives with consent. A family member’s presence must not prevent disclosure of violence, sexual health concerns, mental illness or other sensitive information. 8. Religion and spirituality Spiritual beliefs may provide hope, coping, community support and meaning. They may also influence refusal, fasting, blood-product decisions, end-of-life preferences or the use of prayer alongside treatment. Ask respectfully about spiritual needs and involve chaplaincy or a trusted leader when the patient requests it, without allowing spiritual support to replace urgent medical care. 9. Traditional and complementary healing Patients may use herbs, spiritual care, massage, traditional birth attendants or other healing systems. Ask openly and non-judgementally about products and practices, because some may interact with medicines, delay referral, cause toxicity or be beneficial for wellbeing. Document relevant use, provide risk information and seek collaboration where safe. 10. Stigma and culturally patterned illness Stigma may affect HIV, tuberculosis, epilepsy, infertility, mental illness, disability, cancer, sexual health and substance use. It can lead to secrecy, delayed care, violence and treatment interruption. Use person-first language, protect confidentiality and challenge discriminatory statements. Cultural humility requires ongoing self-reflection rather than claiming to “master” another culture. 11. Cultural competence and cultural humility Self-awareness: recognise personal assumptions, bias and power. Cultural knowledge: learn relevant histories and practices without treating groups as identical. Communication skill: ask, listen, clarify and negotiate. Respect: preserve dignity even when beliefs differ. Adaptation: modify explanations, timing, diet and follow-up when clinically safe. Humility: remain curious and let the patient be the authority on their experience. 12. Cultural safety in clinical care Cultural safety asks whether the patient experiences the service as respectful and free from racism, humiliation and coercion. It includes privacy, language access, appropriate consent, disability access, fair triage, respectful touch and protection from discrimination. A service may consider itself culturally competent while patients still experience it as unsafe; feedback matters. 13. Risks of stereotyping Stereotypes turn a population pattern into an assumption about an individual. Do not assume that every patient from a particular group refuses treatment, uses traditional medicine, wants family involvement or holds the same beliefs. Ask the individual and use clinical evidence. Culture should explain questions, not replace assessment. 14. Applying culture to common clinical situations Antenatal care Ask about food restrictions, birth preferences, family decision-making, traditional birth support and danger-sign knowledge. Mental health Explore local explanations of distress, spiritual support, stigma, safety and preferred forms of help. Chronic disease Adapt diet, medicines and follow-up to work, family roles, food availability and beliefs about long-term treatment. End-of-life care Discuss disclosure, family involvement, spiritual needs, preferred place of care and advance decisions respectfully. 15. A practical cultural assessment What language and form of explanation does the patient prefer? What does the patient think is happening and what caused

Health Behavior: Acquisition, Modification, and Clinical Application 1. The Definition and Role of Health Behavior In modern medicine, chronic diseases (like diabetes, hypertension, and heart disease) have replaced infectious diseases as the leading causes of death. Because these conditions are largely driven by lifestyle, understanding Health Behavior is critical for any healthcare professional. Core Definition Health Behavior refers to any action taken by an individual that affects their health, mortality, or overall well-being. These actions can either promote health (e.g., exercising, getting vaccinated) or compromise health (e.g., smoking, eating a high-sugar diet, ignoring medical advice). Categories of Health Behavior Preventive Health Behavior: Actions taken by a healthy person to prevent illness (e.g., wearing a seatbelt, eating a balanced diet, regular handwashing). Illness Behavior: Actions taken by a person who feels sick to discover what is wrong and find a remedy (e.g., visiting a doctor, researching symptoms online). Sick-Role Behavior: Actions taken by a person who has already been diagnosed, for the purpose of getting well (e.g., adhering to a prescription, undergoing physical therapy, resting). The Clinical Role of Health Behavior The role of health behavior in healthcare cannot be overstated. It is the bridge between a doctor’s prescription and a patient’s recovery. Poor health behavior leads to medical non-adherence (patients not taking their drugs), increased hospital readmissions, and massive healthcare costs. Modifying these behaviors is often more effective than medication alone. 2. Theories of Behavioral Acquisition (How We Learn Behaviors) Before we can change a bad health habit, we must understand how the patient acquired it. Behavioral psychology provides three foundational theories of how behaviors are learned. A. Classical Conditioning (Ivan Pavlov & John B. Watson) This theory explains how we learn through association. An involuntary, natural reflex becomes associated with a completely new, neutral trigger. Mechanism: A neutral stimulus is paired repeatedly with a stimulus that naturally causes a reaction. Eventually, the neutral stimulus alone causes the reaction. Healthcare Examples of Classical Conditioning: White-Coat Hypertension: A patient repeatedly associates the hospital environment (neutral) with stressful or painful procedures (natural trigger). Eventually, just seeing a doctor in a white coat causes their blood pressure to spike, even if no procedure is happening. Anticipatory Nausea in Chemotherapy: A cancer patient receives chemotherapy (natural trigger) which causes vomiting (natural reflex). After a few sessions, the waiting room or the smell of the clinic (neutral) becomes associated with the drug. The patient begins vomiting before the drug is even administered. B. Operant Conditioning (B.F. Skinner) This theory explains that behaviors are acquired and maintained based on their consequences (rewards and punishments). We repeat behaviors that are rewarded and stop behaviors that are punished. Positive Reinforcement Adding a pleasant reward to increase a behavior. Example: A diabetic patient loses 2kg. The doctor heavily praises them and their family celebrates. The patient is motivated to keep exercising. Negative Reinforcement Removing an unpleasant feeling to increase a behavior. Example: A patient has a terrible headache. They take Panadol (Paracetamol), and the pain goes away. They have “learned” to take medication promptly next time they feel pain. Punishment Adding a negative consequence to decrease a behavior. Example: A patient lifts a heavy box using their back instead of their knees and experiences immediate, sharp spine pain. They learn not to lift that way again. C. Social Learning Theory / Social Cognitive Theory (Albert Bandura) Humans do not just learn from direct rewards or associations; we learn primarily through observation and modeling. Mechanism: We watch others perform a behavior, observe the consequences they face, and then imitate them. Healthcare Example: A child grows up in a house where both parents smoke cigarettes to relieve stress. The child observes this coping mechanism and is highly likely to acquire the smoking habit in adulthood. Conversely, observing peers successfully manage their asthma in a support group teaches a newly diagnosed patient how to use an inhaler correctly. 3. Theories of Behavioral Modification (How We Change Behaviors) Knowing how a behavior was learned allows clinicians to use specific models to modify or replace unhealthy habits with healthy ones. A. The Health Belief Model (HBM) Developed in the 1950s, this model suggests that a patient will only change their behavior if they hold specific beliefs about their health. It is heavily used in preventive medicine (like screening and vaccination). Core Belief Definition Healthcare Example (Breast Cancer Screening) Perceived Susceptibility Does the patient believe they are at risk? “My mother had breast cancer, so I know I am at high risk of getting it.” Perceived Severity Does the patient believe the illness is serious? “Breast cancer is deadly; it could kill me and leave my children without a mother.” Perceived Benefits Will the new behavior actually help? “Getting a mammogram can catch the cancer early, saving my life.” Perceived Barriers What is stopping the patient from acting? “The mammogram is expensive, painful, and the clinic is far away.” Cues to Action The trigger that forces the decision. Receiving a reminder text from the clinic, or seeing a billboard about breast cancer. Clinical Goal: The doctor’s job is to increase perceived susceptibility and benefits, while removing barriers (e.g., offering a free or subsidized screening clinic). B. The Transtheoretical Model (Stages of Change) Behavior change is not a single event; it is a long process. A doctor cannot simply tell a smoker to quit and expect them to do it tomorrow. This model identifies the stages a patient moves through to achieve lasting change. 1. Precontemplation Status: Not thinking about change. In denial. Patient: “My grandfather smoked every day and lived to 90. Smoking isn’t hurting me.” Doctor’s Role: Provide gentle education. Do not force action. 2. Contemplation Status: Aware of the problem, considering change in the next 6 months, but hesitant. Patient: “I know smoking makes my cough worse, but it really helps my stress.” Doctor’s Role: Help weigh the pros and cons. 3. Preparation Status: Ready to take action within the next 30 days. Making small steps. Patient: “I bought nicotine patches and